Rahnab Pharmed Investment Holding
FA / EN
Strategic Industrial & Knowledge-Based Infrastructure

Strategic Biopharmaceutical Capabilities

An integrated value chain spanning plasma supply, strategic vaccine and insulin manufacturing, to advanced cell therapies and emergency antivenoms.

01
Tamin Plasma Nozhin Nozhin Zist Pharmed
Plasma Collection & Plasma-Derived Biologics

Plasma Collection & Plasma-Derived Biologics

Plasma Collection & Fractionation

Human plasma collection through a network of eight apheresis centers and production of vital plasma-derived medicines including Albumin, IVIG, Fibrinogen, and Factor VIII.

Technical Specifications & Infrastructure:

Network of 8 apheresis centers, industrial fractionation refinery, Albumin, IVIG, Fibrinogen, and Factor VIII

Executing & Supporting Entities:

Tamin Plasma Nozhin | Nozhin Zist Pharmed

02
Baya Zist Pharmed Strategic Medicines
Insulin & Advanced Drug Manufacturing

Insulin & Advanced Drug Manufacturing

Insulin & Critical Therapeutics

Developing manufacturing capacity for eight types of insulin required by the country to reduce import dependency and secure medication for diabetic patients.

Technical Specifications & Infrastructure:

Automated cartridge filling, cold-chain distribution, biosynthetic formulation, pen delivery systems

Executing & Supporting Entities:

Baya Zist Pharmed

03
Nivad Pharmed Salamat Strategic Vaccines
Vaccine Development & Preventive Health

Vaccine Development & Preventive Health

Recombinant Vaccines & Prevention

Manufacturing Papilloguard and Pneumoguard vaccines and developing Zonaguard to prevent diseases and strengthen national immunization infrastructure.

Technical Specifications & Infrastructure:

VLP recombinant technology, polysaccharide conjugation, national immunization coverage

Executing & Supporting Entities:

Nivad Pharmed Salamat

04
KarayaKhteh Tejhiz Azma Cell Therapy
Cell Therapy & Advanced Immunotherapy

Cell Therapy & Advanced Immunotherapy

Cell Therapy & CAR-T Platforms

Developing and manufacturing CAR-T cells and localizing advanced cellular therapies; advancing toward treating intractable diseases with next-generation technologies.

Technical Specifications & Infrastructure:

GMP cleanroom suites, viral vector transduction, targeted hematologic oncology

Executing & Supporting Entities:

KarayaKhteh Tejhiz Azma

05
Padra Serum Alborz Emergency Biologics
Biological Products & Antivenoms

Biological Products & Antivenoms

Hyperimmune Sera & Antivenoms

Producing approximately 70% of Iran's scorpion and snake antivenom requirements and providing emergency therapeutic sera for venomous envenomation.

Technical Specifications & Infrastructure:

WHO compliance, regional border hospital coverage, equine hyperimmune serum purification

Executing & Supporting Entities:

Padra Serum Alborz

06
Persis Gene Par Pharma Innovation
R&D, Biotechnology & Incubation

R&D, Biotechnology & Incubation

Biotech Acceleration & Venture Incubation

Identifying scientific potential and translating it into scalable products; acting as the essential bridge connecting knowledge, technology, and the modern biopharma industry.

Technical Specifications & Infrastructure:

Fab-lab cleanroom infrastructure, pilot batch manufacturing, VC equity financing

Executing & Supporting Entities:

Persis Gene Par

International Standards & Accreditations

Full Compliance with Global Pharmacopeial Protocols

All manufacturing processes, quality control, and batch release protocols across Rahnab Pharmed adhere to rigorous international standards.

International cGMP Standards

Aseptic manufacturing in Class A and B cleanrooms with continuous particulate and microbial monitoring complying with WHO guidelines.

ISO/IEC 17025 Certification

Reference quality control laboratory collaborating with the IFDA for official Batch Release certification.

World Health Organization (WHO) Protocols

Formulation of antivenoms, sera, and plasma derivatives complying with WHO TRS specifications.

ICH Quality & Stability Standards

Accelerated and real-time stability testing in accordance with ICH Q1A through Q10 guidelines.

Strategic Alliance & Partnership

Ready for Joint Ventures & Strategic Biotech Collaboration?

Rahnab Pharmed direct communications desk is open to business inquiries, technology transfers, and collaborative ventures.

Submit Official B2B Request